BSE filing, NSE: CAMLINFINE. Summary written from the filing by ALFA Finder's alert engine.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹81.70
- Market cap
- ₹1,569 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 266.8×Sector 34.1×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr
Camlin Fine Sciences Management Change
Mr. Pradip Kanakia ceased to be an Independent Director of Camlin Fine Sciences Ltd effective October 18, 2026, upon completion of his five-year term.
Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences Ltd reported the postal ballot voting results for the appointment of Mr. Atul Pradhan as a Non-Executive Independent Director, confirming the resolution's approval.
Camlin Fine Sciences Employee Stock Options
Camlin Fine Sciences Limited allotted 1,200 equity shares to employees exercising vested stock options under its ESOP 2018 scheme. The issue was priced at Rs. 85.00.
- Value
- ₹0.01 Cr
Camlin Fine Sciences Other Announcement
Camlin Fine Sciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This filing provides periodic data regarding the company's current share ownership structure.
Camlin Fine Sciences Other Announcement
Cyrille Damany, classified as 'Other', sold 1,000,000 equity shares of Camlin Fine Sciences Ltd for Rs. 9.75 Crore. The market sale reduced the holder's stake from 0.65% to 0.13%.
- Value
- ₹9.75 Cr
Other management change announcements
All →Equitas Small Finance Bank Management Change
Equitas Small Finance Bank's MD & CEO P. N. Vasudevan resigned effective upon successor appointment. The Board will recommend suitable candidates subject to RBI approval.
Integrated Proteins Management Change
Integrated Proteins appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, effective 29 October 2026. The appointment was approved at a board meeting as a Key Managerial Personnel change.
Suraj Management Change
Suraj Limited appointed Mr. Mayank Balvantbhai Rami as Company Secretary and Compliance Officer effective November 1, 2026. The board approved this KMP appointment on October 29, 2026.
Superior Finlease Management Change
Superior Finlease disclosed that Mr. Krishan Gopal Sharma resigned as CFO and KMP effective 28 Oct 2026 due to personal commitments. No successor is named yet.
Vertex Securities Management Change
Vertex Securities appointed Ms. Unni as Independent Director and Mr. Iyer as CFO, effective October 2026. Both roles were approved at the 28 October board meeting.
Kirloskar Brothers Management Change
Kirloskar Brothers' Independent Directors Vivek Pendharkar and Rekha Sethi completed their 5-year terms on 28 Oct 2026. They ceased from the Board and all committees.